特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DII2015API316)
◆英語タイトル:Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DII2015API316
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模]についてメールでお問い合わせはこちら
当調査レポートでは、特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場について調査・分析し、申請タイプ別上市品の詳細、市販状況別上市品の詳細、APIメーカーの分析、世界販売量予測、上市品別の市場情報、中止された医薬品情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・上市品の分析
-アプリケーション(申請)タイプ別上市品の詳細
-マーケティング(市販)状況別上市品の詳細
-特許権存続期間別上市品の分析
・API(医薬品有効成分)メーカーの分析
 -米国DMF(ドラッグマスターファイル)状況別APIメーカー
 -米国DMF(ドラッグマスターファイル)状況別APIメーカー(Drug Specific)
・上市品の世界販売量予測データ
・上市品別の情報
 -医薬品の説明
 -医薬品の承認状況
 -グローバルAPIメーカー
 -特許及び独占権(Exclusivity)状況
 -企業概要
・中止された医薬品情報
*** レポート概要(サマリー)***

Summary

DelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.
Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

• A snapshot of the global Market therapeutics scenario for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura).
• A review of the marketed products under prescription for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016.


*** レポート目次(コンテンツ)***

Table of Contents
• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2012-2016)
• Marketed Drugs Information
• Drugs Description
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Discontinued Drugs Information

List of Tables
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Application Type, 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, (Year), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, API Manufacturers by US DMF Status, 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, Global Sales (in million USD), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, API Manufacturers, Global, 2015
Discontinued Drugs for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), 2015


List of Figures
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, (Year), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, API Manufacturers by US DMF Status (%), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, Global Sales (in million USD), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, Patent/Exclusivity Expiry (Year), 2015


*** レポートのキーワード ***

特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)、治療薬、上市品、API(原薬)メーカー、製薬、医薬品、市販、DMF(ドラッグマスターファイル)、承認、申請、市場規模

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のピリドキサミン二塩酸塩市場2017
    The 'Global and Chinese Pyridoxamine Dihydrochloride Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Pyridoxamine Dihydrochloride industry with a focus on the Chinese market. The report provides key statistics on the market status o …
  • 2-メチル-6-エチルアニリンの世界市場2018
    The Global 2-Methyl-6-Ethylaniline (CAS 24549-06-2) Industry 2018 Market Research Report is a professional and in-depth study on the current state of the 2-Methyl-6-Ethylaniline industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applicatio …
  • 2014 Analysis of the Japanese Hospital Hematology and Flow Cytometry Market
    This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including: [ul][li][div]Major issues pertaining to the Japanese hematology and flow cytometry practice, as well as key …
  • 無菌パッケージの世界市場2016
    The Global Aseptic Packaging Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Aseptic Packaging industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structu …
  • イギリスのエチルベンゼン市場(~2019):市場規模、シェア、動向
    Ethylbenzene Industry Outlook in the United Kingdom to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalData’s new report, "Ethylbenzene Industry Outlook in the United Kingdom to 2019 - Market Size, Company Share, Price Trends, Capaci …
  • KB Financial Group Inc. (KB) : 企業概要及びSWOT分析
    This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. WMI's 'KB Financial Group Inc. (KB) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, wh …
  • Afren plc (AFR)(石油・ガス分野):企業のM&A・提携動向
    Summary Afren plc (Afren) is an independent upstream energy company. It carries out exploration, appraisal, development and production of oil and natural gas properties. The company holds a portfolio of 28 assets across 12 countries, namely, Nigeria, Congo, Cote d'Ivoire, Ghana, Seychelles, Nigeria …
  • 検査ウィンドウの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Inspection Windows Revenue, means the sales value of Inspection Windows This report studies sales (consumption) of Inspection Windows in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with …
  • 超音波装置の世界市場2017-2026
    According to Stratistics MRC, the Global Ultra Sound Devices market is accounted for $7.80 billion in 2017 and is expected to reach $14.98 billion by 2026 growing at a CAGR of 7.5%. Factors influencing the market growth are increase in the invasive medical and imaging procedures, rising demand for u …
  • 高リン血症治療薬の世界市場:インサイト、市場機会、市場シェア、市場予測
    Hypophosphatemia predicted in patients who have an antiquity of starvation, anorexia/bulimia, alcoholism. Adequate cure comprises phosphate supplements along with feeding and care to causal eating disorders or substance exploitation. The global hypophosphatemia drugs market is driven by increasing a …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DII2015API316 )"特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模" (英文:Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。